Q&A: Nobel winner Fred Ramsdell on basic research in biotech, and the future of cell therapynews2025-10-14T14:41:49+00:00October 14th, 2025|Endpoints News|
Novo Nordisk quits cell therapy as restructure continuesnews2025-10-13T11:05:02+00:00October 13th, 2025|Endpoints News|
Regeneron heads to FDA to seek approval for hearing loss gene therapynews2025-10-13T09:02:48+00:00October 13th, 2025|Endpoints News|
New study suggests patients with anti-AAV antibodies may still receive gene therapynews2025-10-10T18:47:55+00:00October 10th, 2025|Endpoints News|
Cabaletta Bio says small number of autoimmune patients responded to its CAR-T without toxic preconditioningnews2025-10-10T14:35:34+00:00October 10th, 2025|Endpoints News|
Bristol Myers joins in vivo CAR-T race with $1.5B Orbital acquisitionnews2025-10-10T11:28:23+00:00October 10th, 2025|Endpoints News|
Altos Labs is testing anti-aging therapies in organs kept alive outside the bodynews2025-10-09T19:55:46+00:00October 9th, 2025|Endpoints News|
Mammoth Biosciences plans first trial of triglyceride-lowering gene editing therapynews2025-10-09T13:30:56+00:00October 9th, 2025|Endpoints News|
Finnish researchers report success in mid-stage study of heart disease gene therapynews2025-10-09T10:33:04+00:00October 9th, 2025|Endpoints News|
ARPA-H awards several biotechs funding to make in vivo therapiesnews2025-10-08T19:15:18+00:00October 8th, 2025|Endpoints News|
